These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4634795)

  • 1. Topically applied steroids in corneal disease. II. The role of drug vehicle in stromal absorption of dexamethasone.
    Cox WV; Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1972 Nov; 88(5):549-52. PubMed ID: 4634795
    [No Abstract]   [Full Text] [Related]  

  • 2. Topically applied steroids in corneal disease. 3. The role of drug derivative in stromal absorption of dexamethasone.
    Kupferman A; Pratt MV; Suckewer K; Leibowitz HM
    Arch Ophthalmol; 1974 May; 91(5):373-6. PubMed ID: 4821791
    [No Abstract]   [Full Text] [Related]  

  • 3. Topically applied steroids in corneal disease. I. The role of inflammation in stromal absorption of dexamethasone.
    Cox WV; Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1972 Sep; 88(3):308-13. PubMed ID: 5053256
    [No Abstract]   [Full Text] [Related]  

  • 4. Ocular absorption of dexamethasone phosphate disodium by the rabbit.
    Rosenblum C; Dengler RE; Geoffroy RF
    Arch Ophthalmol; 1967 Feb; 77(2):234-7. PubMed ID: 6019020
    [No Abstract]   [Full Text] [Related]  

  • 5. Topically applied steroids in corneal disease. IV. The role of drug concentration in stromal absorption of prednisolone acetate.
    Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1974 May; 91(5):377-80. PubMed ID: 4821792
    [No Abstract]   [Full Text] [Related]  

  • 6. Topically applied steroids in corneal disease. V. Dexamethasone alcohol.
    Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1974 Oct; 92(4):329-30. PubMed ID: 4416662
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of drug vehicles on ocular uptake of tetracycline.
    Hardberger RE; Hanna C; Goodart R
    Am J Ophthalmol; 1975 Jul; 80(1):133-8. PubMed ID: 1155539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular penetration of topically applied mannitol.
    Lazar M; Nowakowski J; Furman M; Shore B
    Am J Ophthalmol; 1970 Nov; 70(5):849-51. PubMed ID: 5477174
    [No Abstract]   [Full Text] [Related]  

  • 9. Topically applied steroids in corneal disease. VI. Kinetics of prednisolone sodium phosphate.
    Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1974 Oct; 92(4):331-4. PubMed ID: 4416663
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of derivatization of the bioavailability of ophthalmic steroids. Development of an in vitro method of evaluation.
    Flint GR; Morton DJ
    Arch Ophthalmol; 1984 Dec; 102(12):1808-9. PubMed ID: 6548906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ophthalmic ointments on intraocular penetration of topical fluorescein in rabbits and man.
    Waltman SR; Buerk K; Foster CS
    Am J Ophthalmol; 1974 Aug; 78(2):262-4. PubMed ID: 4847465
    [No Abstract]   [Full Text] [Related]  

  • 12. Vehicle effects on ocular drug bioavailability II: Evaluation of pilocarpine.
    Sieg JW; Robinson JR
    J Pharm Sci; 1977 Sep; 66(9):1222-8. PubMed ID: 20491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of fluorometholone into the cornea and aqueous humor.
    Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1975 Jun; 93(6):425-7. PubMed ID: 1131082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic steroids and ocular fluid dynamics. II. Systemic versus topical steroids.
    Godel V; Feiler-Ofry V; Stein R
    Acta Ophthalmol (Copenh); 1972; 50(5):664-76. PubMed ID: 4678542
    [No Abstract]   [Full Text] [Related]  

  • 15. Aqueous Humor Penetration and Biological Activity of Moxifloxacin 0.5% Ophthalmic Solution Alone or with Dexamethasone 0.1.
    Gomes RL; Viana RG; Melo LA; Cruz AC; Suenaga EM; Kenyon KR; Campos M
    J Ocul Pharmacol Ther; 2017 Mar; 33(2):98-102. PubMed ID: 28231036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular penetration in rabbits of topically applied dexamethasone.
    Krupin T; Waltman SR; Becker B
    Arch Ophthalmol; 1974 Oct; 92(4):312-4. PubMed ID: 4414887
    [No Abstract]   [Full Text] [Related]  

  • 17. Ophthalmic vehicles. II. Comparison of ointment and polyvinyl alcohol 1.4 per cent.
    Swanson AA; Jeter DJ; Tucker P
    Ophthalmologica; 1970; 160(4):265-70. PubMed ID: 5439166
    [No Abstract]   [Full Text] [Related]  

  • 18. A Nanoparticle-Based Ophthalmic Formulation of Dexamethasone Enhances Corneal Permeability of the Drug and Prolongs Its Corneal Residence Time.
    Nagai N; Nakazawa Y; Ito Y; Kanai K; Okamoto N; Shimomura Y
    Biol Pharm Bull; 2017; 40(7):1055-1062. PubMed ID: 28674248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits.
    Schoenwald RD; Stewart P
    J Pharm Sci; 1980 Apr; 69(4):391-4. PubMed ID: 7373531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Ocular penetration in rabbits of topically applied dexamethasone.
    Leibowitz HM; Kupferman A
    Arch Ophthalmol; 1975 Apr; 93(4):315-7. PubMed ID: 1119972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.